Humana Inc. (NYSE:HUM) Shares Acquired by Synovus Financial Corp

Synovus Financial Corp lifted its stake in shares of Humana Inc. (NYSE:HUM) by 4.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,254 shares of the insurance provider’s stock after purchasing an additional 89 shares during the quarter. Synovus Financial Corp’s holdings in Humana were worth $714,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in HUM. Tidal Investments LLC grew its holdings in Humana by 38.4% in the 3rd quarter. Tidal Investments LLC now owns 24,357 shares of the insurance provider’s stock worth $7,715,000 after buying an additional 6,755 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in Humana in the 3rd quarter worth approximately $948,000. Virtu Financial LLC bought a new position in Humana in the 3rd quarter worth approximately $631,000. TD Private Client Wealth LLC grew its holdings in Humana by 65.9% in the 3rd quarter. TD Private Client Wealth LLC now owns 2,118 shares of the insurance provider’s stock worth $671,000 after buying an additional 841 shares in the last quarter. Finally, Sunbelt Securities Inc. grew its holdings in Humana by 150.3% in the 3rd quarter. Sunbelt Securities Inc. now owns 408 shares of the insurance provider’s stock worth $129,000 after buying an additional 245 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. KeyCorp started coverage on Humana in a research note on Friday, October 11th. They set a “sector weight” rating for the company. JPMorgan Chase & Co. increased their price target on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Finally, Morgan Stanley increased their price target on Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a research note on Tuesday. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Humana currently has a consensus rating of “Hold” and an average target price of $300.50.

Humana Stock Down 10.2 %

HUM stock opened at $233.89 on Wednesday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $475.00. The company has a market cap of $28.16 billion, a PE ratio of 20.72, a price-to-earnings-growth ratio of 2.15 and a beta of 0.53. The business’s 50-day simple moving average is $274.43 and its 200 day simple moving average is $322.89. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, research analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.